 Anna Furniss
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 12 | 2025 | 1428 | 0.740 |
Why?
| | Klinefelter Syndrome | 3 | 2025 | 69 | 0.580 |
Why?
| | Turner Syndrome | 3 | 2025 | 65 | 0.570 |
Why?
| | Neurodevelopmental Disorders | 4 | 2025 | 229 | 0.510 |
Why?
| | Parents | 7 | 2025 | 1404 | 0.490 |
Why?
| | Papillomavirus Vaccines | 4 | 2024 | 296 | 0.470 |
Why?
| | Mental Disorders | 4 | 2025 | 1169 | 0.430 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2025 | 39 | 0.380 |
Why?
| | Overweight | 5 | 2023 | 614 | 0.370 |
Why?
| | Reminder Systems | 3 | 2016 | 140 | 0.320 |
Why?
| | Transgender Persons | 2 | 2024 | 210 | 0.310 |
Why?
| | Text Messaging | 3 | 2016 | 182 | 0.290 |
Why?
| | Safety-net Providers | 2 | 2021 | 130 | 0.280 |
Why?
| | Papillomavirus Infections | 3 | 2024 | 344 | 0.260 |
Why?
| | Health Surveys | 3 | 2025 | 520 | 0.240 |
Why?
| | Weight Loss | 3 | 2017 | 859 | 0.230 |
Why?
| | Growth Charts | 1 | 2025 | 20 | 0.230 |
Why?
| | Adolescent | 20 | 2025 | 22569 | 0.230 |
Why?
| | Anxiety | 2 | 2025 | 1122 | 0.230 |
Why?
| | Rural Health Services | 2 | 2024 | 138 | 0.220 |
Why?
| | Hypertension | 3 | 2022 | 1276 | 0.210 |
Why?
| | Female | 38 | 2025 | 79025 | 0.210 |
Why?
| | Sex Chromosome Disorders | 1 | 2025 | 27 | 0.210 |
Why?
| | Weight Reduction Programs | 2 | 2017 | 140 | 0.210 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2024 | 14 | 0.210 |
Why?
| | Body Height | 1 | 2025 | 203 | 0.210 |
Why?
| | Child | 18 | 2025 | 22738 | 0.210 |
Why?
| | Trisomy | 1 | 2025 | 78 | 0.200 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2024 | 122 | 0.200 |
Why?
| | Neurofilament Proteins | 1 | 2024 | 79 | 0.200 |
Why?
| | Obesity | 5 | 2023 | 3118 | 0.200 |
Why?
| | Rural Population | 3 | 2024 | 660 | 0.200 |
Why?
| | Healthcare Disparities | 3 | 2024 | 736 | 0.200 |
Why?
| | Urban Population | 2 | 2024 | 494 | 0.190 |
Why?
| | Colorado | 9 | 2025 | 4556 | 0.190 |
Why?
| | Food Assistance | 1 | 2023 | 31 | 0.190 |
Why?
| | Internal Medicine | 1 | 2025 | 279 | 0.190 |
Why?
| | Ambulatory Care | 2 | 2025 | 610 | 0.180 |
Why?
| | Male | 30 | 2025 | 72992 | 0.180 |
Why?
| | Postpartum Period | 2 | 2023 | 373 | 0.180 |
Why?
| | Humans | 45 | 2025 | 145750 | 0.180 |
Why?
| | Genetic Linkage | 2 | 2022 | 273 | 0.180 |
Why?
| | Physicians, Primary Care | 1 | 2024 | 208 | 0.180 |
Why?
| | Cardiovascular Diseases | 3 | 2025 | 2190 | 0.170 |
Why?
| | Dental Caries | 1 | 2023 | 173 | 0.170 |
Why?
| | Gender Dysphoria | 1 | 2021 | 19 | 0.170 |
Why?
| | Disorders of Sex Development | 1 | 2021 | 40 | 0.170 |
Why?
| | Electronic Health Records | 3 | 2025 | 1202 | 0.170 |
Why?
| | Mood Disorders | 1 | 2021 | 144 | 0.160 |
Why?
| | Dyslipidemias | 1 | 2022 | 184 | 0.160 |
Why?
| | Child, Preschool | 9 | 2025 | 11866 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2024 | 1419 | 0.150 |
Why?
| | Liver Diseases | 1 | 2022 | 305 | 0.140 |
Why?
| | Practice Patterns, Physicians' | 2 | 2024 | 1372 | 0.140 |
Why?
| | Infant | 9 | 2025 | 10089 | 0.140 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2019 | 36 | 0.140 |
Why?
| | Case-Control Studies | 5 | 2025 | 3634 | 0.140 |
Why?
| | Logistic Models | 5 | 2021 | 2139 | 0.140 |
Why?
| | Feasibility Studies | 1 | 2023 | 1115 | 0.140 |
Why?
| | United States | 12 | 2025 | 16122 | 0.140 |
Why?
| | Communication | 1 | 2025 | 976 | 0.140 |
Why?
| | Adult | 17 | 2025 | 40867 | 0.140 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 100 | 0.140 |
Why?
| | Information Seeking Behavior | 1 | 2018 | 40 | 0.130 |
Why?
| | Osteoprotegerin | 1 | 2017 | 22 | 0.130 |
Why?
| | Genome-Wide Association Study | 2 | 2022 | 1430 | 0.130 |
Why?
| | Exome | 1 | 2019 | 229 | 0.130 |
Why?
| | Cardiologists | 1 | 2017 | 45 | 0.130 |
Why?
| | Precision Medicine | 1 | 2022 | 461 | 0.130 |
Why?
| | Organizations, Nonprofit | 1 | 2017 | 17 | 0.130 |
Why?
| | Birth Order | 1 | 2017 | 14 | 0.130 |
Why?
| | Lost to Follow-Up | 1 | 2017 | 20 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.130 |
Why?
| | Infant, Newborn | 7 | 2025 | 6464 | 0.130 |
Why?
| | Population Density | 1 | 2017 | 89 | 0.120 |
Why?
| | Qualitative Research | 1 | 2024 | 1676 | 0.120 |
Why?
| | Hearing Tests | 1 | 2017 | 53 | 0.120 |
Why?
| | Parenting | 1 | 2020 | 319 | 0.120 |
Why?
| | Health Promotion | 3 | 2023 | 775 | 0.120 |
Why?
| | Genome, Human | 1 | 2019 | 422 | 0.120 |
Why?
| | Time-to-Treatment | 1 | 2018 | 251 | 0.120 |
Why?
| | Attitude of Health Personnel | 1 | 2024 | 1196 | 0.120 |
Why?
| | Patient Readmission | 1 | 2021 | 772 | 0.120 |
Why?
| | Blood Pressure | 2 | 2022 | 1782 | 0.120 |
Why?
| | Cross-Sectional Studies | 6 | 2025 | 5921 | 0.110 |
Why?
| | Young Adult | 9 | 2025 | 14250 | 0.110 |
Why?
| | Renal Dialysis | 3 | 2009 | 466 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 534 | 0.110 |
Why?
| | Neonatal Screening | 1 | 2017 | 179 | 0.110 |
Why?
| | Middle Aged | 15 | 2025 | 36297 | 0.110 |
Why?
| | Aftercare | 1 | 2017 | 222 | 0.110 |
Why?
| | Influenza, Human | 1 | 2021 | 624 | 0.110 |
Why?
| | Depression | 1 | 2025 | 1557 | 0.110 |
Why?
| | Adolescent Health Services | 1 | 2015 | 74 | 0.110 |
Why?
| | Prevalence | 4 | 2025 | 2874 | 0.110 |
Why?
| | Down Syndrome | 1 | 2021 | 525 | 0.110 |
Why?
| | Exercise Test | 1 | 2017 | 630 | 0.110 |
Why?
| | Odds Ratio | 3 | 2021 | 1083 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 364 | 0.100 |
Why?
| | Genetic Variation | 1 | 2019 | 976 | 0.100 |
Why?
| | Hearing Loss | 1 | 2017 | 249 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 402 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4302 | 0.090 |
Why?
| | Prediabetic State | 1 | 2016 | 250 | 0.090 |
Why?
| | Age of Onset | 2 | 2025 | 557 | 0.090 |
Why?
| | Myocardium | 1 | 2017 | 935 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2383 | 0.090 |
Why?
| | Risk Assessment | 1 | 2021 | 3752 | 0.090 |
Why?
| | Gonadotropin-Releasing Hormone | 2 | 2024 | 217 | 0.090 |
Why?
| | Kidney Failure, Chronic | 2 | 2009 | 599 | 0.090 |
Why?
| | Patient Compliance | 1 | 2016 | 588 | 0.090 |
Why?
| | Poverty | 3 | 2023 | 528 | 0.090 |
Why?
| | Appointments and Schedules | 2 | 2025 | 96 | 0.080 |
Why?
| | Urban Health Services | 2 | 2021 | 69 | 0.080 |
Why?
| | Cohort Studies | 4 | 2025 | 6032 | 0.080 |
Why?
| | Aged | 9 | 2025 | 26212 | 0.070 |
Why?
| | Estradiol | 2 | 2023 | 515 | 0.070 |
Why?
| | Propensity Score | 2 | 2021 | 377 | 0.070 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 6084 | 0.070 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2009 | 20 | 0.070 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 96 | 0.070 |
Why?
| | Retrospective Studies | 7 | 2021 | 17322 | 0.060 |
Why?
| | Risk Factors | 5 | 2021 | 10916 | 0.060 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 104 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2393 | 0.060 |
Why?
| | Minority Groups | 2 | 2018 | 285 | 0.060 |
Why?
| | XYY Karyotype | 1 | 2025 | 24 | 0.050 |
Why?
| | Body Mass Index | 3 | 2025 | 2447 | 0.050 |
Why?
| | Sex Chromosome Disorders of Sex Development | 1 | 2025 | 17 | 0.050 |
Why?
| | Washington | 1 | 2025 | 149 | 0.050 |
Why?
| | Time Factors | 4 | 2018 | 7133 | 0.050 |
Why?
| | Guatemala | 2 | 2016 | 343 | 0.050 |
Why?
| | Chromosomes, Human, X | 1 | 2025 | 77 | 0.050 |
Why?
| | Hospitals | 2 | 2021 | 733 | 0.050 |
Why?
| | Sex Chromosome Aberrations | 1 | 2025 | 69 | 0.050 |
Why?
| | Muscular Atrophy | 1 | 2005 | 87 | 0.050 |
Why?
| | Psychotropic Drugs | 1 | 2025 | 78 | 0.050 |
Why?
| | Reference Values | 1 | 2025 | 798 | 0.050 |
Why?
| | Heart Failure | 1 | 2017 | 2326 | 0.050 |
Why?
| | Smoking | 2 | 2024 | 1477 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5428 | 0.050 |
Why?
| | Sleep Wake Disorders | 1 | 2007 | 314 | 0.050 |
Why?
| | Dental Hygienists | 1 | 2023 | 14 | 0.050 |
Why?
| | Neuroglia | 1 | 2024 | 174 | 0.050 |
Why?
| | Patient Acceptance of Health Care | 2 | 2022 | 883 | 0.050 |
Why?
| | Motivational Interviewing | 1 | 2025 | 121 | 0.050 |
Why?
| | Job Satisfaction | 1 | 2025 | 238 | 0.050 |
Why?
| | Isometric Contraction | 1 | 2005 | 190 | 0.050 |
Why?
| | Testosterone Congeners | 1 | 2022 | 7 | 0.050 |
Why?
| | Cigarette Smoking | 1 | 2024 | 102 | 0.050 |
Why?
| | Vaccination Coverage | 1 | 2024 | 102 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8346 | 0.040 |
Why?
| | Body Weight | 1 | 2025 | 972 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2025 | 712 | 0.040 |
Why?
| | Linear Models | 2 | 2017 | 849 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2022 | 178 | 0.040 |
Why?
| | Lower Extremity | 1 | 2005 | 445 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2024 | 911 | 0.040 |
Why?
| | Child Behavior Disorders | 1 | 2021 | 119 | 0.040 |
Why?
| | Motor Activity | 1 | 2005 | 718 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 287 | 0.040 |
Why?
| | Autism Spectrum Disorder | 1 | 2025 | 423 | 0.040 |
Why?
| | Comorbidity | 1 | 2025 | 1662 | 0.040 |
Why?
| | Influenza Vaccines | 1 | 2024 | 534 | 0.040 |
Why?
| | Recombinases | 1 | 2019 | 10 | 0.040 |
Why?
| | Burnout, Professional | 1 | 2025 | 488 | 0.040 |
Why?
| | Mental Health | 1 | 2025 | 796 | 0.040 |
Why?
| | Testosterone | 1 | 2022 | 416 | 0.030 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 66 | 0.030 |
Why?
| | Attitude | 1 | 2020 | 259 | 0.030 |
Why?
| | Suicidal Ideation | 1 | 2024 | 583 | 0.030 |
Why?
| | Developmental Disabilities | 1 | 2021 | 281 | 0.030 |
Why?
| | Mentors | 1 | 2020 | 217 | 0.030 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 222 | 0.030 |
Why?
| | Quality of Life | 2 | 2007 | 3210 | 0.030 |
Why?
| | Mississippi | 1 | 2017 | 28 | 0.030 |
Why?
| | Nuclear Family | 1 | 2018 | 50 | 0.030 |
Why?
| | Health Personnel | 1 | 2024 | 755 | 0.030 |
Why?
| | Hospitalization | 2 | 2024 | 2460 | 0.030 |
Why?
| | Health Behavior | 1 | 2023 | 789 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1897 | 0.030 |
Why?
| | Patient Care Team | 1 | 2023 | 697 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 427 | 0.030 |
Why?
| | Altitude | 1 | 2021 | 463 | 0.030 |
Why?
| | Mastectomy | 1 | 2018 | 185 | 0.030 |
Why?
| | Pediatricians | 1 | 2018 | 121 | 0.030 |
Why?
| | Alcoholism | 1 | 2024 | 826 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 7215 | 0.030 |
Why?
| | Maternal Age | 1 | 2017 | 128 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2024 | 843 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2967 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2018 | 244 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 388 | 0.030 |
Why?
| | Quality Improvement | 1 | 2025 | 1296 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2019 | 248 | 0.030 |
Why?
| | Suicide | 1 | 2024 | 729 | 0.030 |
Why?
| | Emigration and Immigration | 1 | 2017 | 66 | 0.030 |
Why?
| | Obstetrics | 1 | 2018 | 177 | 0.030 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2016 | 28 | 0.030 |
Why?
| | Income | 1 | 2017 | 203 | 0.030 |
Why?
| | Peru | 1 | 2016 | 60 | 0.030 |
Why?
| | Haemophilus Vaccines | 1 | 2016 | 29 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2024 | 1101 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2017 | 225 | 0.030 |
Why?
| | Rotavirus Vaccines | 1 | 2016 | 39 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 375 | 0.030 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2016 | 48 | 0.030 |
Why?
| | Hepatitis B Vaccines | 1 | 2016 | 43 | 0.030 |
Why?
| | Algorithms | 1 | 2023 | 1850 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 79 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1491 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3170 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1652 | 0.030 |
Why?
| | Cell Phone | 1 | 2016 | 82 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1711 | 0.030 |
Why?
| | Women's Health | 1 | 2017 | 316 | 0.030 |
Why?
| | Educational Status | 1 | 2017 | 470 | 0.030 |
Why?
| | Prognosis | 3 | 2009 | 4329 | 0.030 |
Why?
| | Immunization Schedule | 1 | 2016 | 186 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1791 | 0.030 |
Why?
| | Echocardiography | 1 | 2017 | 648 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1474 | 0.030 |
Why?
| | Insurance, Health | 1 | 2017 | 311 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 655 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2022 | 2181 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 544 | 0.030 |
Why?
| | Immunization Programs | 1 | 2016 | 193 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1327 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1973 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1547 | 0.030 |
Why?
| | Primary Health Care | 1 | 2024 | 1736 | 0.020 |
Why?
| | Sexual Behavior | 1 | 2018 | 495 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2399 | 0.020 |
Why?
| | Medicaid | 1 | 2017 | 467 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2017 | 756 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2017 | 587 | 0.020 |
Why?
| | Vascular Stiffness | 1 | 2017 | 487 | 0.020 |
Why?
| | Sex Factors | 1 | 2017 | 2110 | 0.020 |
Why?
| | Program Evaluation | 1 | 2016 | 943 | 0.020 |
Why?
| | Caregivers | 1 | 2020 | 1073 | 0.020 |
Why?
| | Exercise | 1 | 2023 | 2203 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 2000 | 0.020 |
Why?
| | Decision Making | 1 | 2018 | 981 | 0.020 |
Why?
| | Mothers | 1 | 2016 | 765 | 0.020 |
Why?
| | Cognition | 1 | 2018 | 1271 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1582 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2009 | 330 | 0.020 |
Why?
| | Japan | 1 | 2007 | 149 | 0.020 |
Why?
| | Europe | 1 | 2007 | 421 | 0.020 |
Why?
| | Electric Impedance | 1 | 2005 | 108 | 0.010 |
Why?
| | Survival Rate | 1 | 2009 | 2094 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2007 | 426 | 0.010 |
Why?
| | Survival Analysis | 1 | 2006 | 1378 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 2123 | 0.010 |
Why?
| | Gait | 1 | 2005 | 312 | 0.010 |
Why?
| | Body Composition | 1 | 2005 | 693 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 11793 | 0.010 |
Why?
| | Adipose Tissue | 1 | 2005 | 645 | 0.010 |
Why?
| | Walking | 1 | 2005 | 542 | 0.010 |
Why?
|
|
Furniss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|